This is the authors' abstract. We don't add key points for this paper.
Since their discovery and development, human induced pluripotent stem cells (iPSCs) have brought about notable advances in biomedical science and have become an essential infrastructure for medical research and applications. This review discusses the current status of iPSC-based cell therapies, drug discovery, and therapeutic developments for neurodegenerative diseases with unmet medical needs. It also highlights research approaches employing cohorts of iPSCs derived from sporadic neurodegenerative diseases to advance prevention and diagnostic support. It further considers future directions for the use of iPSCs in the treatment of neurodegenerative disorders.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Haruhisa Inoue (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: